This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Augmentation of Risperidone With Valproic Acid

Siow-Ann Chong, Chay-Hoon Tan, Ee-Lian Lee, and Pei-Hsiang Liow

Published: August 15, 1998

Article Abstract

Sir: The response of psychotic symptoms following the addition of valproate to typical antipsychotic medications has shown conflicting results. The combination of risperidone, lithium, and valproate has been reported to be efficacious in patients with bipolar disorder. We report a patient with schizophrenia for whom the addition of valproic acid to treatment with a typical antipsychotic had no effect on psychotic symptomatology but for whom marked improvement occurred when valproic acid was added to risperidone.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: Dementia , Neurologic and Neurocognitive

Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...